Irene Tennant, the head of clinical development and regulatory affairs at AGT, speaks about her role in the development of gene and cell therapies to treat human diseases. She works… [Read More]
Progression of a Gene Therapy Company, Jeff Galvin, CEO and Irene Tennant, VP of AGT
In this video, Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company, built to cure diseases that were previously… [Read More]
About Gene Therapy, Jeff Galvin, CEO of AGT
In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system.
Cell and Gene Therapy Approach, Jeff Galvin, CEO of AGT
Gene therapy is accelerating at an incredibly fast and impressive rate. AGT is at the forefront of this progress, fuelling the gene therapy market.
Cell Therapy Manufacturing, C. David Pauza, Ph.D., CSO of AGT
This video explains the ins and outs of cell therapy. Dr. C. David Pauza, Chief Science Officer of American Gene Technologies, explains how one tiny dot on a cell, a… [Read More]